Gland Pharma

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue824.36919.281,0521,1411,222
Expenses655.99665.29704.71769.50789.09
EBITDA208.09294.57388.22412.88479.78
EBIT114.09255.59347.97372.56437.22
Profit Before Tax111.91253.99347.07371.76432.69
Net Profit79.21187.58257.53276.81321.41
Financial Ratios
Operating Profit Margin19.31%33.32%38.41%37.61%40.84%
Net Profit Margin14.50%21.22%25.48%25.21%27.36%
Earning Per Share (Diluted)4.8111.3915.6316.8019.51
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.0.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ